Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

My Six Cents: How to Help a Patient Feel Seen & Heard

Samantha C. Shapiro, MD  |  February 26, 2025

Compassion, clear communication, empathy and more—Samantha C. Shapiro, MD, provides practical advice on how to connect with your patients during appointments.

Filed under:Opinion Tagged with:bedside mannerclinical carecommunicationOpinionpatient carepatient communication

Ekemini A. Ogbu, MD, MSc, FAAP, Leads the Pediatric Rheumatology Committee

Gretchen Henkel  |  February 17, 2025

The new chair of the ACR’s Pediatric Rheumatology Committee, Ekemini A. Ogbu, MD, MSc, FAAP, describes how helping children and families navigate complex care brings a sense of fulfillment, purpose and “just joy.”

Filed under:Career DevelopmentProfiles Tagged with:ACR’s Pediatric Rheumatology Special Committee

Deucravacitinib Promising for PsA

Michele B. Kaufman, PharmD, BCGP  |  February 12, 2025

Results from two studies found that deucravacitinib improved the signs and symptoms of patients with psoriatic arthritis who were biologic disease-modifying anti-rheumatic drug naive and those previously treated with a tumor necrosis factor α inhibitor.

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:deucravacitinibPsoriatic Arthritis

FDA Approval Sought for 2 Pediatric Indications for Guselkumab

Michele B. Kaufman, PharmD, BCGP  |  February 11, 2025

The FDA is reviewing supplemental biologics license applications for guselkumab to treat children with juvenile psoriatic arthritis and moderate to severe plaque psoriasis.

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:FDA approvalguselkumabjuvenile idiopathic arthritis (JIA)pediatric plaque psoriasis

Editor's Pick

The Burden Imposed by Prior Authorization Requirements

Deborah Levenson  |  February 9, 2025

‘Prior authorizations are the bane of our existence as rheumatologists,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘How bad is it, how can we manage them, and how is the ACR helping?  Read on in this month’s Editor’s Pick.’ Healthcare providers consider prior authorization (PA) a significant burden, but to different degrees…

Filed under:Patient PerspectivePractice SupportTechnology Tagged with:artificial intelligenceprior authorization

3 AC&R Study Summaries: Maternal Health & SLE, Pregnancy Outcomes & Coordinated Ophthalmic & Rheumatologic Care

Arthritis Care & Research  |  February 7, 2025

Maternal Health Insights in Patients with SLE The impact of pregnancy readiness on lupus activity, maternal mental health & pregnancy outcomes By Ceshae Harding, MD, & Megan Clowse, MD, MPH Why was this study done? Patients with systemic lupus erythematosus (SLE) who are pregnant have increased risks of risks maternal and fetal mortality, preeclampsia and…

Filed under:ConditionsResearch ReviewsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RopthalmologistpregnancyReading RheumUveitis

Precision Medicine on a Population Level

Daniel H. Solomon, MD, MPH, & Andrew Concoff, MD, FACR  |  February 6, 2025

Guest columnists Dr. Daniel Solomon & Dr. Andrew Concoff discuss the potential of technology, such as mobile health apps, to enhance remote care & improve access for underserved patients.

Filed under:OpinionPractice ManagementPractice SupportSpeak Out RheumTechnologyWorkforceWorkforce Tagged with:healthcare accessPrecision Medicine

Rheuminations: How to Counteract Patients’ Eroding Trust in Healthcare

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  February 5, 2025

At first, there was an incomprehensibly loud explosion. And out of that explosion, about 4.5 billion years afterward, emerged the world’s first rheumatologist. Only a few notable things have happened between these two events, but the most important dynamic has been the continuous expansion of our universe. If the speculations of many cosmologists are correct,…

Filed under:OpinionPatient PerspectiveRheuminations Tagged with:adherencepatient-clinician relationshiptrust

mRNA CAR T Cell Therapy Receives FDA’s Rare Pediatric Designation to Treat Juvenile Dermatomyositis

Michele B. Kaufman, PharmD, BCGP  |  January 30, 2025

FDA has granted Descartes-08, an mRNA chimeric antigen receptor T cell therapy, a rare pediatric disease designation for the treatment of juvenile dermatomyositis.

Filed under:Biologics/DMARDsConditionsDrug UpdatesMyositis Tagged with:chimeric antigen receptor T (CAR-T) cellsFDAjuvenile dermatomyositisU.S. Food and Drug Administration (FDA)

Reproductive Health, Biosimilars & More in Focus at SOTA 2025

Ruth Jessen Hickman, MD  |  January 30, 2025

Reproductive health, biosimilars, IgG4-related disease and much more—five speakers give us a sneak peek into important topics being addressed at the ACR’s 2025 State-of-the-Art Clinical Symposium, April 4–6.

Filed under:Biologics/DMARDsConditionsEducation & TrainingGuidanceMeeting ReportsOther ACR meetings Tagged with:ACR State-of-the-Art Clinical SymposiumBiosimilarsIgG4 related diseaseLupusOsteoporosispregnancypregnancy complicationspregnant womenskinState-of-the-Art Clinical Symposium

  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences